Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
35 /100
MEDIUM RISK
Score updated Oct 27, 2026

ARCT — Arcturus Therapeutics Holdings Inc. Dilution Risk Tracker

Track ARCT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ARCT — Get alerts when the score changes →

As of October 27, 2026, Arcturus Therapeutics Holdings Inc. (ARCT) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. Arcturus Therapeutics Holdings Inc. has a market capitalization of $280.54M, 28.42M shares outstanding, 127 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
25
📊 Float Risk
20
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for ARCT.
🔔 Track ARCT — Get forecast alerts →

Market Data

Market Cap$280.54M
Shares Outstanding28.42M
Float26.15M
Cash$191.48M
Debt$75.66M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore35/100DilutionWatch score record
Shares Outstanding28.42MVerified float table or market cache
Public Float26.15MVerified float table or market cache
Market Cap$280.54MMarket data cache
Cash Runway23.9 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 0.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

ARCT SEC Filing Activity — Last 12 Months

Shares outstanding reported by ARCT on the cover page of its latest 10-K/10-Q: 28.42M as of August 04, 2026.

DilutionWatch recorded 1 registration or prospectus document for ARCT (the filings through which shares are offered) in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
S-3shelf registration1Dec 30, 2025
8-Kcurrent report (material event)6Aug 25, 2026
10-Qquarterly report1Aug 06, 2026
SC 13G/Aamended passive >5% holder filing1Oct 07, 2026
4insider transaction8Jun 15, 2026
3initial insider ownership3May 07, 2026

Institutional Holdings

QoQ: ↑ 14.4% shares (2026Q1 vs prior)
127 institutional holders · 28.54M shares
#1 FEDERATED HERMES, INC. 3.30M shares
#2 ARK Investment Management LLC 2.77M shares
#3 BlackRock, Inc. 2.61M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest5.46M
Days to Cover8.4
% of Float20.9%
FINRA data as of Oct 15, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news available for this ticker.

DilutionScore History — Last 90 Days

ARCT's DilutionScore is currently 35/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 31/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 27, 202635/100MEDIUM67 days
Jul 30 – Aug 21, 202631/100MEDIUM22 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

ARCT shares outstanding have increased 0.0% from 28.41M (Mar 2026) to 28.42M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 08, 202628.42M26.15M▼ 0.50%
Mar 05, 202628.41M26.28M▲ 0.04%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track ARCT Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ARCT files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ARCT — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,566+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ARCT
ARCT FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.